Discovery of aldolase A inhibitors via high-throughput screening assay based on an enzymatic coupling reaction
文献类型:期刊论文
| 作者 | Xiong, Qingwen1,2; Qian, Rongyu1,2; Huang, Qingcheng2; Liu, Jingqiu2; Zhou, Chen3; Luo, Cheng1,2; Liu, Dongxiang1,2; Du, Daohai2 |
| 刊名 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
![]() |
| 出版日期 | 2025-12-01 |
| 卷号 | 128页码:7 |
| 关键词 | ALDOA Enzymatic coupling reaction High-throughput screening Inhibitor |
| ISSN号 | 0960-894X |
| DOI | 10.1016/j.bmcl.2025.130332 |
| 英文摘要 | Aldolase A (ALDOA) is a key enzyme in glycolysis, catalyzing the reversible conversion of fructose-1,6-diphosphate (FBP) to dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GAP). The aberrant overexpression of ALDOA is associated with the development of various solid tumors. Here, we developed an in vitro enzymatic coupling reaction assay, which demonstrates high cost-efficiency and is suitable for high-throughput screening (HTS). With this assay we identified two potential ALDOA inhibitors, merbromin and ellagic acid, from our in-house compound library. Merbromin and ellagic acid exhibit significant inhibitory activities with IC50 values of 8.49 f 0.62 mu M and 19.87 f 2.03 mu M, respectively. The nuclear magnetic resonance (NMR) and surface plasmon resonance (SPR) experiments further confirmed their high affinities to ALDOA, with the dissociation constants (Kd) of 0.49 f 0.10 mu M and 0.64 f 0.10 mu M, respectively. Enzyme kinetics experiment revealed that both compounds act as noncompetitive inhibitors of ALDOA. Our study showed that the enzymatic coupling reaction-based assay established here is highly effective and offers a promising approach for the development of ALDOA inhibitors. |
| WOS关键词 | FRUCTOSE-1,6-BISPHOSPHATE ; SUBSTRATE ; GLUCOSE |
| 资助项目 | National Key Research and Development Program of China[2022YFC3400500] ; National Natural Science Foun-dation of China[92253303] ; National Natural Science Foun-dation of China[22337004] ; National Natural Science Foun-dation of China[82341017] |
| WOS研究方向 | Pharmacology & Pharmacy ; Chemistry |
| 语种 | 英语 |
| WOS记录号 | WOS:001537564600001 |
| 出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/321117] ![]() |
| 专题 | 国家级研究中心_原创新药研究全国重点实验室 |
| 通讯作者 | Liu, Dongxiang; Du, Daohai |
| 作者单位 | 1.Nanjing Univ Chinese Med, Sch Chinese Mat Med, 138 Xianlin Rd, Nanjing 210023, Jiangsu, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Chem Biol Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China |
| 推荐引用方式 GB/T 7714 | Xiong, Qingwen,Qian, Rongyu,Huang, Qingcheng,et al. Discovery of aldolase A inhibitors via high-throughput screening assay based on an enzymatic coupling reaction[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2025,128:7. |
| APA | Xiong, Qingwen.,Qian, Rongyu.,Huang, Qingcheng.,Liu, Jingqiu.,Zhou, Chen.,...&Du, Daohai.(2025).Discovery of aldolase A inhibitors via high-throughput screening assay based on an enzymatic coupling reaction.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,128,7. |
| MLA | Xiong, Qingwen,et al."Discovery of aldolase A inhibitors via high-throughput screening assay based on an enzymatic coupling reaction".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 128(2025):7. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。

